Dimitrios Iliopoulos, University of California, Los Angeles, USA
Dr. Iliopoulos received his Ph.D from the Integrative Biomedical Science Graduate Program at Ohio State University in 2006. He completed his postdoctoral fellowship in the laboratory of Dr. Kevin Struhl, a world expert in molecular genetics, at the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School.
In 2010, Dr. Iliopoulos become Assistant Professor in the Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute, and the Department of Microbiology & Immunobiology, Harvard Medical School. Currently, Dr. Iliopoulos is an Associate Professor in the Division of Digestive Diseases at David Geffen School of Medicine at UCLA and Director of the Center for Systems Biomedicine, a high technology center combining robotics and bioinformatics aiming to expedite the drug discovery process for different inflammatory and metabolic diseases.
Dr. Iliopoulos has extensive experience in the development and use of high throughput technologies and systems biology approaches. His innovative methodology has revolutionized and expedited the drug discovery process and he is interested in applying these strategies to identify novel therapeutic agents against gastrointestinal diseases including inflammatory bowel diseases and colon, liver and pancreatic cancers. His pioneering work on the anti-diabetic drug metformin and cancer stem cells, led to the initiation of several phase II and phase III clinical trials to test the efficacy of combining chemotherapy with metformin for cancer treatment. Dr. Iliopoulos is a member of the American Gastroenterology Association (AGA), the American Association for Cancer Research (AACR) and the International Society for Computational Biology (ISCB).